NCT06434402
A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer
Active, Not Recruiting
NAAges 18–39InterventionalSupportive careM.D. Anderson Cancer CenterInvestigator-initiated
~30 participants
Updated 2026-07-16 on ClinicalTrials.gov
What's tested:Behavioral Intervention
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Study Completion Rate
Measured over At 1 month follow-up
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesTexas1
Study leadership
- Qian Lu, MD,PHD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age 15 - 39 years at cancer diagnosis
Age 18 - 39 years at study entry
Diagnosed between 1 and 5 years ago prior to enrollment
Can speak, read, and write in English
Exclusion
Nonmelanoma skin cancer
Major mental health disorder (e.g., schizophrenia or bipolar disorder \[determined from patient records or self-disclosure\])
No internet access.
What this trial measures
- Study Completion RateAt 1 month follow-up
The Study completion rate is defined as the average proportion of participants who complete follow-up assessments at 1-month follow-up. We will also calculate the 95% confidence intervals for the study completion rate.
- Intervention Adherence RateAt the end of intervention (week 8)
The intervention adherence rate will be calculated as the number of completed writing tasks divided by the total number of assigned tasks (4).